Browsing by Subject "Surrogate endpoints."
Now showing items 1-1 of 1
Bayesian evaluation and adaptive trial design for surrogate time-to-event endpoints in clinical trials. (2011-05-12)Surrogate endpoints are desirable in clinical trials when primary endpoints are costly to obtain, difficult to measure, or require lengthy follow-up to observe. Despite legitimate concerns, evaluation of potentially ...